Evidence map›Paper›PMID 25680477›Full record

ArticleStem cell reports2015

Use of RUNX2 expression to identify osteogenic progenitor cells derived from human embryonic stem cells.

Li Zou, Fahad K Kidwai, Ross A Kopher, Jason Motl, Cory A Kellum, Jennifer J Westendorf, Dan S Kaufman

Open access · goldAbstract read
In one paragraph

Article in Stem cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Icariin Promotes Fracture Healing in Ovariectomized Rats.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. The effect of Mg-Ca-Sr alloy degradation products on human mesenchymal stem cells.Journal of biomedical materials research. Part B, Applied biomaterials · 2018
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Li ZouDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Fahad K KidwaiDiagnostic/Biological Sciences, School of Dentistry, University of Minnesota, Minneapolis, MN 55455, USA.
Ross A KopherDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Jason MotlDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Cory A KellumDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
Jennifer J WestendorfDepartment of Orthopedic Surgery, Mayo Clinic, Rochester, MN 55905, USA.
Dan S KaufmanDepartment of Medicine, University of Minnesota, Minneapolis, MN 55455, USA. Electronic address: kaufm020@umn.edu.
University of Minnesota · USWinnMed · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
Osteogenic Repair from Human Pluripotent Stem CellsR01DE022556 · NIDCR · UNIVERSITY OF MINNESOTA · PI KAUFMAN, DAN S. · 2011 to 2014
$1.5M
Minnesota Craniofacial Research Training ProgramR90DE023058 · NIDCR · UNIVERSITY OF MINNESOTA · PI MANSKY, KIM CARPENTER · 2012 to 2022
$1.2M
NCI NIH HHS P30 CA077598NIDCR NIH HHS DE022556NIDCR NIH HHS R01 DE022556NIDCR NIH HHS R90 DE023058
6 · The paper itself

Abstract

We generated a RUNX2-yellow fluorescent protein (YFP) reporter system to study osteogenic development from human embryonic stem cells (hESCs). Our studies demonstrate the fidelity of YFP expression with expression of RUNX2 and other osteogenic genes in hESC-derived osteoprogenitor cells, as well as the osteogenic specificity of YFP signal. In vitro studies confirm that the hESC-derived YFP(+) cells have similar osteogenic phenotypes to osteoprogenitor cells generated from bone-marrow mesenchymal stem cells. In vivo studies demonstrate the hESC-derived YFP(+) cells can repair a calvarial defect in immunodeficient mice. Using the engineered hESCs, we monitored the osteogenic development and explored the roles of osteogenic supplements BMP2 and FGF9 in osteogenic differentiation of these hESCs in vitro. Taken together, this reporter system provides a novel system to monitor the osteogenic differentiation of hESCs and becomes useful to identify soluble agents and cell signaling pathways that mediate early stages of human bone development.

Indexed as

AnimalsCell DifferentiationCell LineCore Binding Factor Alpha 1 SubunitEmbryonic Stem CellsGene ExpressionGenes, ReporterHumansImmunophenotypingMesenchymal Stem CellsMiceOsteogenesisPhenotypeCore Binding Factor Alpha 1 Subunit

Identifiers

PMID25680477
PMCPMC4325195
OpenAlexW2057588710

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.